RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care

Clinical trial NCT07187570 · RECRUITING

Trial details

NCT number: NCT07187570
Sponsor: Region Stockholm
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation (AF)

Start date: 2025-06-03
Primary completion: 2027-12-01
Enrollment: 1600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.